{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:22:32Z","timestamp":1779200552451,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.ejpn.2008.12.006","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T03:27:57Z","timestamp":1234409277000},"page":"541-545","source":"Crossref","is-referenced-by-count":29,"title":["An open-label, prospective study of levetiracetam in children and adolescentes with Tourette syndrome"],"prefix":"10.1016","volume":"13","author":[{"given":"Alberto","family":"Fern\u00e1ndez-Ja\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Mart\u00edn","family":"Fern\u00e1ndez-Mayoralas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Mu\u00f1oz-Jare\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Calleja-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2008.12.006_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1469-8749.2003.tb00402.x","article-title":"Prevalence of tic disorders and Tourette syndrome in a Swedish school population","volume":"45","author":"Khalifa","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/1469-7610.00802","article-title":"The prevalence of Tourette syndrome in 13\u201314-year-olds in mainstream schools","volume":"42","author":"Hornse","year":"2001","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.ejpn.2008.12.006_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(05)01012-4","article-title":"Tourette's syndrome: from behaviour to biology","volume":"4","author":"Singer","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib4","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.33588\/rn.38S1.2004084","article-title":"S\u00edndrome de Tourette: an\u00e1lisis de su comorbilidad y sus tratamientos espec\u00edficos","volume":"38","author":"Castellanos","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0733-8619(05)70321-2","article-title":"Tourette s\u00edndrome. Treatment of tics","volume":"15","author":"Kurlan","year":"1997","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ejpn.2008.12.006_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00007611-198809000-00009","article-title":"Clonazepam, haloperidol, and clonidine in tic disorders","volume":"81","author":"Troung","year":"1988","journal-title":"South Med J"},{"key":"10.1016\/j.ejpn.2008.12.006_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00004583-199403000-00014","article-title":"Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD","volume":"33","author":"Steingard","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2008.12.006_bib8","first-page":"245","article-title":"Clonidine and clonazepam in Tourette syndrome","volume":"58","author":"Goetz","year":"1992","journal-title":"Adv Neurol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib9","first-page":"158","article-title":"Control of Tourette\u2019s syndrome with topiramate","volume":"6","author":"Abuzzahaf","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ejpn.2008.12.006_bib10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.ejpn.2008.12.006_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tins.2006.01.001","article-title":"Recent advances in Tourette syndrome research","volume":"29","author":"Albin","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ejpn.2008.12.006_bib12","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0387-7604(03)90012-X","article-title":"Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities","volume":"25","author":"Singer","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.ejpn.2008.12.006_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1212\/WNL.56.5.599","article-title":"Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial","volume":"56","author":"Singer","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.12.006_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/088307389901400508","article-title":"Tics in Tourette syndrome: new treatment options","volume":"14","author":"Awaad","year":"1999","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib15","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejpn.2008.12.006_bib16","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)","volume":"96","author":"Crowder","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejpn.2008.12.006_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1358\/dot.2007.43.11.1136902","article-title":"Levetiracetam","volume":"43","author":"Carre\u00f1o","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.ejpn.2008.12.006_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1059-1311(03)00193-6","article-title":"Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience","volume":"13","author":"Tan","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.ejpn.2008.12.006_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eplepsyres.2004.03.006","article-title":"Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy","volume":"59","author":"Coppola","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.ejpn.2008.12.006_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.WNF.0000228807.49044.7D","article-title":"Levetiracetam in tardive dyskinesia","volume":"29","author":"Meco","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib21","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/mds.21061","article-title":"Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington\u2019s disease","volume":"21","author":"Zesiewicz","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2008.12.006_bib22","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1212\/01.WNL.0000154596.21335.2E","article-title":"The effect of levetiracetam on essential tremor","volume":"64","author":"Bushara","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejpn.2008.12.006_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.33588\/rn.4503.2006227","article-title":"Eficacia y tolerabilidad del levetiracetam en pacientes con temblor esencial: datos de un ensayo abierto de 11 semanas de seguimiento","volume":"45","author":"Sanz-Cartagena","year":"2007","journal-title":"Rev Neurol"},{"key":"10.1016\/j.ejpn.2008.12.006_bib24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/mds.20385","article-title":"Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome","volume":"20","author":"Awaad","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2008.12.006_bib25","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/mds.21615","article-title":"A double-blind randomized placebo-control trial of levetiracetam in Tourette syndrome","volume":"22","author":"Smith-Hicks","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejpn.2008.12.006_bib26","first-page":"38","article-title":"Effect of levetiracetam on truncal tic in neuroacanthocytosis","volume":"15","author":"Lin","year":"2006","journal-title":"Acta Neurol Taiwan"},{"key":"10.1016\/j.ejpn.2008.12.006_bib27","first-page":"1","article-title":"Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome","volume":"8","author":"Oulis","year":"2007","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.ejpn.2008.12.006_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1469-8749.2002.tb00820.x","article-title":"Tics and psychiatric comorbidity in children and adolescents","volume":"44","author":"Gadow","year":"2002","journal-title":"Dev Med Child Neurol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379809000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379809000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:55:53Z","timestamp":1738947353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379809000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1090379809000038"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2008.12.006","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}